Stay updated on Olezarsen in Hypertriglyceridemia and CVD Clinical Trial
Sign up to get notified when there's something new on the Olezarsen in Hypertriglyceridemia and CVD Clinical Trial page.

Latest updates to the Olezarsen in Hypertriglyceridemia and CVD Clinical Trial page
- Check4 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the study history.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedCore study content sections were added to the record, including Study Description, Study Status, Arms and Interventions, Outcome Measures, Baseline Characteristics, Participant Flow, Adverse Events, References, and Document Section. The update also notes a Returned date (2026-03-19) and that Quality Control Review Has Not Concluded.SummaryDifference1%

- Check33 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the study record history.SummaryDifference0.1%

- Check40 days agoChange DetectedThe record history now includes a new revision entry v3.4.3 and removes the v3.4.2 entry.SummaryDifference0.1%

- Check47 days agoChange DetectedThe study record status changed from 'No Results Posted' to 'Results Submitted', indicating that trial results have been submitted.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; a minor site version change that does not affect study data or visible content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Olezarsen in Hypertriglyceridemia and CVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olezarsen in Hypertriglyceridemia and CVD Clinical Trial page.